gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 11 Dec 2014.

Epidermal growth factor receptor

EGFR
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene. [provided by RefSeq, Jul 2010] (from NCBI)
Top mentioned proteins: HAD, CAN, erbB-2, Epidermal Growth Factor, Akt
Papers using EGFR antibodies
Studying lipids involved in the endosomal pathway.
Supplier
Johannes Ludger, In PLoS ONE, 2011
... South San Francisco, CA); EEA1 (Transduction Laboratories); LAMP1 (CD107a; BD Biosciences); EGFR (BD Biosciences); α-tubulin (Sigma- Aldrich) ...
Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
Supplier
Croce Carlo M. et al., In Nature medicine, 2010
... Targeting of both the c-Met and EGFR pathways results in additive inhibition of lung tumorigenesis in transgenic mice ...
Total internal reflection STED microscopy
Supplier
Bewersdorf Joerg et al., In Biomedical Optics Express, 2010
... A linker encoding the signal sequence of EGFR was inserted into 5′ MCS of pSNAPf vector (New England Biolabs) using the unique NheI ...
Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: role of MMP-10 in VEGF-induced angiogenesis.
Supplier
Gaetano Carlo, In PLoS ONE, 2009
... Materials: The antibodies of VEGF, PEDF, TNF-α, epidermal growth factor receptor (EGFR) were purchased from Abcam, Cambridge, MA, USA ...
Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains.
Supplier
Caplan Steve H., In PLoS ONE, 2009
... Louis, MO), and mouse anti-EGFR was from Cell signaling technology (Danvers, MA) ...
more suppliers
Papers on EGFR
Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.
Review
New
Band et al., Baltimore, United States. In World J Clin Oncol, 10 Jan 2015
UNLABELLED: Epidermal growth factor receptor (EGFR) controls a wide range of cellular processes, and aberrant EGFR signaling as a result of receptor overexpression and/or mutation occurs in many types of cancer.
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.
Review
New
Behera et al., Chandīgarh, India. In World J Clin Oncol, 10 Jan 2015
They are both tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR).
Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.
New
Yokoyama et al., Kanazawa, Japan. In Clin Exp Nephrol, 10 Jan 2015
There was no significant difference in baseline laboratory data and electron microscopic findings, except for eGFR and serum IgG levels.
Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
New
Agarwal et al., Aurora, United States. In Mol Carcinog, 09 Jan 2015
Both agents also inhibited the mitogenic signaling by reducing EGFR, ERK1/2, Akt, and STAT3 phosphorylation and suppressed the activation of transcription factors NF-κB and AP-1.
MET amplification status in therapy-naïve adeno- and squamous cell carcinomas of the lung.
New
Buettner et al., Köln, Germany. In Clin Cancer Res, 09 Jan 2015
Importantly, MET amplifications occur at equal frequencies in squamous and adenocarcinomas without or with EGFR or KRAS mutations.
Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.
New
Impact
Mok et al., Boston, United States. In Lancet Oncol, 31 Dec 2014
BACKGROUND: Patients with EGFR-mutant non-small-cell lung cancer generally have a progression-free survival of 9-13 months while being treated with the EGFR tyrosine-kinase inhibitors gefitinib or erlotinib.
Navigating later lines of treatment for advanced colorectal cancer - Optimizing targeted biological therapies to improve outcomes.
Review
New
Berry et al., Vancouver, Canada. In Cancer Treat Rev, 31 Dec 2014
Targeted biological agents with varying modes of action are now approved for use in second-line and beyond, including the VEGF-inhibitors bevacizumab and aflibercept, the VEGFR/multikinase-inhibitor regorafenib, and the EGFR-inhibitors cetuximab and panitumumab.
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
New
Impact
Slack et al., New Haven, United States. In Nature, 17 Dec 2014
Some of the most effective anticancer therapies target oncogenes such as EGFR and HER2; similarly, inhibition of oncomiRs using antisense oligomers (that is, antimiRs) is an evolving therapeutic strategy.
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
New
Impact
Engelman et al., Boston, United States. In Science, 13 Dec 2014
We established cell culture models derived from biopsy samples of lung cancer patients whose disease had progressed while on treatment with EGFR or ALK tyrosine kinase inhibitors and then subjected these cells to genetic analyses and a pharmacological screen.
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
New
Impact
Paz-Ares et al., Atlanta, United States. In Lancet Oncol, 30 Nov 2014
BACKGROUND: Dacomitinib is an irreversible pan-EGFR family tyrosine kinase inhibitor.
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.
New
Impact
NCI Naples Clinical Trials Unit et al., Hamilton, Canada. In Lancet Oncol, 30 Nov 2014
Patients were stratified according to centre, performance status, tobacco use, best response to previous EGFR tyrosine-kinase inhibitor, weight loss within the previous 3 months, and ethnicity, and were then randomly allocated 2:1 to oral dacomitinib 45 mg once-daily or matched placebo centrally via a web-based system.
Putting together structures of epidermal growth factor receptors.
Review
New
Lemmon et al., Philadelphia, United States. In Curr Opin Struct Biol, 24 Nov 2014
UNLABELLED: Numerous crystal structures have been reported for the isolated extracellular region and tyrosine kinase domain of the epidermal growth factor receptor (EGFR) and its relatives, in different states of activation and bound to a variety of inhibitors used in cancer therapy.
Epidermal growth factor receptor gene expression evaluation in colorectal cancer patients.
New
Talaee et al., Sārī, Iran. In Indian J Cancer, Jul 2014
Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor that shows over expression in epithelial tumors and regulates important processes in tumorigenesis.
Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
Review
New
Sudol, Singapore, Singapore. In Sci Signal, Dec 2013
In this issue of Science Signaling, a study by Haskins et al. has brought an end to this scenario of an "orphaned" pathway by identifying neuregulin 1 and its cognate receptor ERBB4 [epidermal growth factor receptor (EGFR) family member v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4] as a major receptor complex that activates YAP activity.
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
New
Stern et al., New Haven, United States. In Sci Signal, Dec 2013
The receptor tyrosine kinase ERBB4, a member of the epidermal growth factor receptor (EGFR) family, is unusual in that ERBB4 can undergo intramembrane proteolysis, releasing a soluble intracellular domain (ICD) that modulates transcription in the nucleus.
The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.
GeneRIF
Kudo et al., Japan. In Gan To Kagaku Ryoho, 2012
high concentration of gefitinib is not necessary to achieve long-term therapeutic effects in patients with lung adenocarcinoma harboring the EGFR mutation
Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
GeneRIF
Pike et al., Saint Louis, United States. In J Biol Chem, 2012
a molecular explanation for the apparent preference of the EGF receptor for dimerizing with ErbB2 and suggest that the phosphorylation of ErbB2 occurs largely in the context of the EGFR/ErbB2 heterodimer
Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.
Impact
GeneRIF
Wang et al., Beijing, China. In J Clin Oncol, 2012
Chemotherapy may reduce EGFR mutation frequency in patients with non-small cell lung carcinoma, likely the result of a preferential response of subclones with EGFR mutations in tumors with heterogeneous tumor cell populations.
[Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma].
GeneRIF
Petera et al., Hradec Králové, Czech Republic. In Strahlenther Onkol, 2012
An increase of EGFR expression during chemoradiation may be associated with significantly shorter DFS and OS.
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
GeneRIF
Pichaud et al., London, United Kingdom. In Development, 2012
Atonal and EGFR signalling orchestrate rok- and Drak-dependent adherens junction remodelling during ommatidia morphogenesis.
More papers using EGFR antibodies
Emerging roles of Wnts in the adult nervous system.
Supplier
Katoh Masaru, In PLoS ONE, 2009
... Anti phospho-ERK1/2, antiphospho-EGFR (Tyr1068 and Tyr1086), antiphospho-Akt (S473) and total EGFR antibodies were from Cell Signaling Technology Inc (Danvers, MA, ...
Treatment of eccrine porocarcinoma with metastasis to the parotid gland using intensity-modulated radiation therapy: a case report
Supplier
Hoque Mohammad O., In PLoS ONE, 2009
... CA), ER (SP1, prediluted, Ventana Medical Systems, Tucson, AZ), PR (1E2, prediluted, Ventana Medical Systems), EGFR (3C6, prediluted, Ventana Medical Systems), and HER2 (4B5, prediluted, ...
Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice.
Supplier
Sun Shi-Yong, In PLoS ONE, 2008
Santa Cruz), anti-β-Tubulin and -β-Actin (Sigma-Aldrich); and anti-phospho-EGFR (Y1086, Abcam), and anti-EGFR, -ERK, -Akt ...
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Supplier
Richardson Andrea L et al., In Breast Cancer Research : BCR, 2008
... USA), CK18 (DC10 antibody, Dako) and CK19 (RCK108 antibody, Dako) as well as for EGFR (EGFR pharmDX kit, Dako) and p53 (DO-7 antibody, ...
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer
Supplier
Smrdel Uros et al., In Journal of Biomedicine and Biotechnology, 2008
... To detect EGFR gene-activating mutations, we used TheraScreen EGFR29 Mutation Kit (DxS Diagnostics, Qiagen, Manchester, UK) ...
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Supplier
Carvalho Luzia Helena, In PLoS ONE, 2008
... Antibodies to GAPDH, EGFR, MCP-1, and RANTES were purchased from Santa Cruz Biotechnology, Inc ...
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
Supplier
Domagala Wenancjusz et al., In Virchows Archiv, 2008
... EGFR staining was performed using the EGFR pharmDx kit (Dako) with incubation with proteinase ...
HGF-independent Potentiation of EGFR Action by c-Met
Supplier
Siegfried Jill M. et al., In Oncogene, 2007
... Mouse anti-c-Met, rabbit anti-EGFR, rabbit anti-Y1234/35-Met and anti-rabbit and anti-mouse-HRP linked secondary antibodies were obtained from Cell Signaling (Beverly, MA) ...
Close-to-native ultrastructural preservation by high pressure freezing
Supplier
Bergmann Andreas, In PLoS ONE, 2007
... The following EGFR RNAi transgenic lines were used: ...
Lysine acetylation: codified crosstalk with other posttranslational modifications
Supplier
Sorkin Alexander et al., In The Journal of Cell Biology, 2007
... monoclonal antibody to ubiquitin (P4D1), rabbit polyclonal antibodies to Grb2, Cbl (C-15), Shc (H-108), and EGFR (1005) were purchased from Santa Cruz Biotechnology, Inc ...
Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.
Supplier
Holowka David, In PLoS ONE, 2007
... Cruz Biotechnology, Santa Cruz, CA, USA) and mouse anti-alpha tubulin (Sigma-Aldrich, Milan, Italy) and rabbit anti-EGFR (Cell Signaling Celbio, Milan, Italy) antibodies ...
Neuroprotection and stroke: time for a compromise
Supplier
Docagne Fabian et al., In The Journal of Experimental Medicine, 2006
... Rabbit anti–mouse pErk1/2 and pAkt and anti–mouse phosphorylated EGFR antibodies were obtained from Cell Signaling Technology ...
Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation.
Supplier
Munderloh Ulrike Gertrud, In PLoS ONE, 2006
... antibody against phospho-IκBα, IκBα, phospho-IKKα/β, IKKα, IKKβ, phospho-p38, p38, phospho-MKK3/6, MKK3, phospho-Akt, Akt, phospho-EGFR and EGFR were purchased from Cell Signaling (MA, USA) ...
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Supplier
Waugh M G et al., In Cell Death & Disease, 2006
... Anti-EGFR was from Cell Signaling Technologies (Hertfordshire, UK) and ...
Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung
Supplier
van Oosterhout Antoon J et al., In Respiratory Research, 2006
... EGFR and phospho-EGFR detected by western blotting using anti-phospho-EGFR (1173 tyrosine residue) and anti-EGFR (Santa Cruz Biotechnology, Santa Cruz, CA) ...
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Supplier
Wang J M et al., In British Journal of Cancer, 2006
... against phosphorylated Akt, Akt, phosphorylated p38, p38, phosphorylated Erk, Erk, phosphorylated EGFR (tyrosine 992) and EGFR were from Cell Signaling Technology (Beverly, MA, USA) ...
Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting.
Supplier
Lewin Alfred, In PLoS ONE, 2005
... To prepare the substrate for selection, human EGFR-Fc protein was immobilized to Protein G magnetic beads (New England Biolabs, Ipswich, MA) as follows: ...
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Supplier
Cordes Nils, In PLoS ONE, 2005
... indicated suppliers: Cell Signaling Technologies: phospho-IGF-1R (tyrosine 1131/1135/1136), phospho-Akt (Ser 473), Akt, cleaved PARP, phospho-STAT3, EGFR and Akt1; Santa Cruz Biotechnology: IGF-1R, PTK6, Erk2, tubulin; ...
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of Rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Supplier
Blagosklonny Mikhail V., In PLoS ONE, 2005
... were all obtained from Cell Signaling Technology Inc (Danvers, MA) and anti-p-Tyr-EGFR1173 as well as anti-EGFR were from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
Supplier
Chen Hong-Chen et al., In Journal of Biomedical Science, 2004
... Monoclonal anti-EGFR (ab30) was purchased from Abcam.
Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables
Supplier
Wulf Gerburg M et al., In Breast Cancer Research : BCR, 2004
... Phycoerythrin (PE)-conjugated mouse anti-EGFR antibody (EGFR.1,
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Supplier
Rodemann H Peter et al., In Molecular Cancer, 2004
... The EGFR-inhibitory antibody Erbitux was purchased from Merck KG aA, Germany and ...
Signal transduction for protease-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells
Supplier
Inagaki Chiyoko et al., In Respiratory Research, 2004
... human TGF-β1 was from Peprotech EC (Margravine Rode, London, UK); antibodies against E-cadherin, GAPDH and phospho-EGFR (specific for Tyr1173) were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, ...
Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline
Supplier
Wells A et al., In British Journal of Cancer, 2004
... Primary antibodies to phospho-EGFR (Cell Signaling, Danvers, MA, USA), ...
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor
Supplier
Press M F et al., In British Journal of Cancer, 2003
... A polyclonal rabbit antibody to the C-terminus epitope of EGFR was obtained from Santa Cruz Biotechnology, Santa Cruz, CA, USA ...
Label-Free Quantitation of Protein Modifications by Pseudo Selected Reaction Monitoring with Internal Reference Peptides
Supplier
Ham Amy-Joan L. et al., In Journal of Proteome Research, 2003
For Western blotting, primary antibodies forphosphotyrosine site 1172, phosphotyrosine site 998 and EGFR were purchased from Cell Signaling Technology (Danvers, MA) ...
Expression of luminal and basal cytokeratins in human breast carcinoma
Supplier
Pogoda Katarzyna et al., In Journal of Neuro-Oncology, 2003
... Immunohistochemistry for cytokeratin 5/6 (Clone D5/16B4, DAKO, dilution scale 1:100), HER1 (EGFR pharm Dx, Clone 2-18C9, DAKO, RTU) and c-KIT (CD117, ...
Age-related changes in VEGF-dependency and angiopoietin-1 induced plasticity of adult blood vessels.
Supplier
Welm Alana L., In PLoS ONE, 2003
... The antibodies against VEGF (human-specific) and EGFR were purchased from Epitomics Inc ...
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
Supplier
Hynes Nancy E et al., In Breast cancer research : BCR, 2003
... used in this study: extracellular signal-regulated kinase 1/2 (ERK1/2), p-ERK1/2, total β-catenin, poly(ADP-ribose)polymerase (PARP), EGFR, p-EGFR (tyrosine [Tyr] 845), and p-Tyr-100 (Cell Signaling Technology, Inc., Danvers, MA, ...
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
Supplier
Nurminsky Dmitry I., In PLoS ONE, 2002
... (Abcam, ab654), Glut3 (made in Devaskar's lab, UCLA), Glut1 (Abcam, ab15309), IGFR (Cell Signaling, 111A9), EGFR, (Santacruz, sc 03, 1005), Glucose-6-P dehydrogenase (Abcam, ab34436), Protein Kinase C-zeta ...
Can correct protein models be identified?
Supplier
Jensen-Jarolim Erika et al., In Molecular Immunology, 2002
... removed with xylene from sections and immunohistochemistry was performed using the FDA-approved in vitro diagnostic EGFR pharm Dx™ (DAKO, Glostrup, Denmark) and HercepTest ...
CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas: correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients
Supplier
Saxena Sunita et al., In The Indian Journal of Medical Research, 2002
... the biomarkers- AR (Neomarkers; Fremont, CA, 1:50); ER (DAKO; Denmark, 1:50); PR (DAKO; Denmark, 1:50); EGFR (DAKO; Denmark, 1:50) and CD105 ...
Efficient expression system of human recombinant laminin-5.
Supplier
Chakravarti Shukti, In PLoS ONE, 2001
... integrin α6 (GoH3); mouse mAbs to integrin α3 (P1B5) and EGFR (528); rabbit pAbs to EGFR (1005), and integrin ß4 (H101) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); ...
Nesca, a novel adapter, translocates to the nuclear envelope and regulates neurotrophin-induced neurite outgrowth
Supplier
Meakin Susan O. et al., In The Journal of Cell Biology, 2001
... Other primary antibodies used were EGFR and GFP (Santa Cruz Biotechnology, Inc.), phospho-p44/42 MapK (New ...
The investigation of death from diseases caused by coal-burning type of arsenic poisoning
Supplier
Waalkes Michael P. et al., In Environmental Health Perspectives, 2001
... (sc-1616) and poly-clonal antibodies against cyclin D1 (sc-753), cdk4 (sc-601), and endothelial growth factor receptor (EGFR, sc-03) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA) ...
Atomic model of the papillomavirus capsid.
Supplier
Imperiale Michael, In PLoS Pathogens, 2001
... siRNA cell transfection was performed using Lipofectamine 2000 reagent (Invitrogen), with EGFR siRNA (Cell Signaling) according to manufacturer's recommendations ...
Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells
Supplier
Friess Helmut et al., In Molecular Cancer, 2000
... Phospho-PDGFR-beta (tyr857) and p-EGFR (tyr1173) polyclonal antibodies were purchased from Santa Cruz Biotechnology, Inc ...
Gene Expression Omnibus
Supplier
Golub Todd R et al., In Genome Biology, 1998
... EGFR and mouse cKIT antibodies were purchased from Santa Cruz Biotechnology [ ...
Protein tyrosine phosphorylation influences adhesive junction assembly and follicular organization of cultured thyroid epithelial cells
Supplier
Turner T et al., In British Journal of Cancer, 1996
... -catenin, and p120 (Transduction Laboratories, California, USA), phosphorylated MARCKS (Cell Signaling, Massachusetts, USA), phosphorylated EGFR (Cell Signaling, Massachusetts, USA), and EGFR ...
Prevention of radiolysis of monoclonal antibody during labeling
Supplier
van Dongen Guus A. M. S. et al., In European Journal of Nuclear Medicine and Molecular Imaging, 1995
... MAb cetuximab (Erbitux; 2.0 mg/ml) directed against the epidermal growth factor receptor (EGFR) was purchased from Merck (Darmstadt, Germany) [ ...
The stress activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
Supplier
Adler G et al., In British Journal of Cancer, 1995
... , and the EGFR were obtained from Santa Cruz Biotechnology (Santa Cruz, USA) ...
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
Supplier
Poulsen H S et al., In British Journal of Cancer, 1989
... The antiphospho-EGFR (Tyr1086) antibody was from Biosource (USA).Antibody to tubulin was from Santa Cruz Biotechnology Inc ...
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose
Supplier
Johannes Ludger, In PLoS ONE, 1983
... The following primary antibodies were used: rabbit anti-EGFR antibody (Cell Signaling Technology); rabbit anti-COX IV ...
Nonparametric estimator from incomplete observations.
Supplier
Minna John D., In PLoS ONE, 1957
... Anti-EGFR (SC-03) antibody from Santa Cruz Biotechnology, Inc ...
share on facebooktweetadd +1mail to friends